Ascendis Pharma A/S
NASDAQ:ASND

Watchlist Manager
Ascendis Pharma A/S Logo
Ascendis Pharma A/S
NASDAQ:ASND
Watchlist
Price: 170.8 USD -0.07% Market Closed
Market Cap: 10.3B USD

Relative Value

The Relative Value of one ASND stock under the Base Case scenario is hidden USD. Compared to the current market price of 170.8 USD, Ascendis Pharma A/S is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ASND Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
77
vs Industry
28
Median 3Y
32.6
Median 5Y
181
Industry
7.2
Forward
14
vs History
vs Industry
Median 3Y
-13.7
Median 5Y
-15.4
Industry
23.2
Forward
-37.8
vs History
vs Industry
Median 3Y
-14.1
Median 5Y
-18.5
Industry
19.3
vs History
vs Industry
Median 3Y
-26.1
Median 5Y
-22.6
Industry
22.5
vs History
vs Industry
0
Median 3Y
-22.9
Median 5Y
7.7
Industry
2.7
vs History
85
vs Industry
23
Median 3Y
33.8
Median 5Y
169.3
Industry
7.5
Forward
13.9
vs History
50
vs Industry
21
Median 3Y
42.1
Median 5Y
28.5
Industry
9.4
vs History
vs Industry
Median 3Y
-12.5
Median 5Y
-16.8
Industry
4.6
Forward
-42.8
vs History
vs Industry
Median 3Y
-12.1
Median 5Y
-16.3
Industry
4.5
Forward
-37.2
vs History
vs Industry
Median 3Y
-13.3
Median 5Y
-18.4
Industry
4.9
vs History
vs Industry
Median 3Y
-12.9
Median 5Y
-17.6
Industry
3.7
vs History
55
vs Industry
13
Median 3Y
19.2
Median 5Y
20.5
Industry
4.9

Multiples Across Competitors

ASND Competitors Multiples
Ascendis Pharma A/S Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
DK
Ascendis Pharma A/S
NASDAQ:ASND
10.4B USD 24.5 -26.4 -28.8 -27.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 361 436.7 -163 314.8 -198 316.3 -196 053.2
US
Abbvie Inc
NYSE:ABBV
337.5B USD 5.9 81.2 15.4 22.8
US
Amgen Inc
NASDAQ:AMGN
158.7B USD 4.7 26.8 14.4 23.7
US
Gilead Sciences Inc
NASDAQ:GILD
136.9B USD 4.8 23 10 13.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117B USD 10.5 -118.3 25.2 26.4
US
Epizyme Inc
F:EPE
94.1B EUR 2 050.2 -523.2 -569.7 -554.5
AU
CSL Ltd
ASX:CSL
116.1B AUD 4.9 27.4 16.9 21.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
57.3B USD 4.1 12.7 11.3 12.7
US
Seagen Inc
F:SGT
39.3B EUR 19.7 -60.6 -65.3 -58.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
40.1B USD 17.1 -148.8 -666.4 -333.9
P/S Multiple
Revenue Growth P/S to Growth
DK
Ascendis Pharma A/S
NASDAQ:ASND
Average P/S: 3 123 962.1
24.5
69%
0.4
FR
Pharnext SCA
OTC:PNEXF
34 361 436.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.9
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.7
4%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.8
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.5
10%
1.1
US
E
Epizyme Inc
F:EPE
2 050.2
N/A N/A
AU
CSL Ltd
ASX:CSL
4.9
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.1
4%
1
US
S
Seagen Inc
F:SGT
19.7
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
17.1
29%
0.6
P/E Multiple
Earnings Growth PEG
DK
Ascendis Pharma A/S
NASDAQ:ASND
Average P/E: 34.2
Negative Multiple: -26.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -163 314.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
81.2
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.8
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -118.3 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -523.2 N/A N/A
AU
CSL Ltd
ASX:CSL
27.4
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.7
7%
1.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -148.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DK
Ascendis Pharma A/S
NASDAQ:ASND
Average EV/EBITDA: 15.5
Negative Multiple: -28.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -198 316.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.4
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.4
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
10
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -569.7 N/A N/A
AU
CSL Ltd
ASX:CSL
16.9
11%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.3
11%
1
US
S
Seagen Inc
F:SGT
Negative Multiple: -65.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -666.4 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
DK
Ascendis Pharma A/S
NASDAQ:ASND
Average EV/EBIT: 20.1
Negative Multiple: -27.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -196 053.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.8
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.7
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.8
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.4
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -554.5 N/A N/A
AU
CSL Ltd
ASX:CSL
21.2
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.7
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.9 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -333.9 N/A N/A